Carol Collins
Overview
Explore the profile of Carol Collins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lenherr-Taube N, Furman M, Assor E, Elia Y, Collins C, Thummel K, et al.
J Clin Endocrinol Metab
. 2021 Jun;
106(10):2938-2948.
PMID: 34139759
Context: Idiopathic infantile hypercalcemia (IIH) is an uncommon disorder with variable clinical features. The natural history and response to dietary calcium and vitamin D restriction in IIH remains unclear. Objective:...
2.
Lenherr-Taube N, Young E, Furman M, Elia Y, Assor E, Chitayat D, et al.
J Clin Endocrinol Metab
. 2021 Jun;
106(10):2915-2937.
PMID: 34125233
Context: Idiopathic infantile hypercalcemia (IIH), an uncommon disorder characterized by elevated serum concentrations of 1,25 dihydroxyvitamin D (1,25(OH)2D) and low parathyroid hormone (PTH) levels, may present with mild to severe...
3.
Grizzle A, Horn J, Collins C, Schneider J, Malone D, Stottlemyer B, et al.
J Med Internet Res
. 2019 Jan;
21(1):e11182.
PMID: 30609981
Background: Preventing drug interactions is an important goal to maximize patient benefit from medications. Summarizing potential drug-drug interactions (PDDIs) for clinical decision support is challenging, and there is no single...
4.
Zhang H, Basit A, Busch D, Yabut K, Bhatt D, Drozdzik M, et al.
Biochem Pharmacol
. 2018 Aug;
156:32-42.
PMID: 30086285
Protein abundance and activity of UGT2B17, a highly variable drug- and androgen-metabolizing enzyme, were quantified in microsomes, S9 fractions, and primary cells isolated from human liver and intestine by validated...
5.
Lie L, Shetty V, Gupta K, Polifka J, Markham G, Albee S, et al.
AMIA Annu Symp Proc
. 2018 Jun;
2017:1100-1109.
PMID: 29854178
Healthcare providers (HCPs) caring for pregnant patients often need information on drug risks to the embryo or fetus, but such complex information takes time to find and is difficult to...
6.
Kraft J, McConnachie L, Koehn J, Kinman L, Sun J, Collier A, et al.
J Control Release
. 2018 Feb;
275:229-241.
PMID: 29432823
Existing oral antiretroviral (ARV) agents have been shown in human studies to exhibit limited lymph node penetration and lymphatic drug insufficiency. As lymph nodes are a reservoir of HIV, it...
7.
Kraft J, McConnachie L, Koehn J, Kinman L, Collins C, Shen D, et al.
AIDS
. 2017 Jan;
31(6):765-770.
PMID: 28099191
Objective: The aim of the present study was to determine whether a combination of anti-HIV drugs - tenofovir (TFV), lopinavir (LPV) and ritonavir (RTV) - in a lipid-stabilized nanosuspension (called...
8.
Wang L, Collins C, Kelly E, Chu X, Ray A, Salphati L, et al.
Drug Metab Dispos
. 2016 Aug;
44(11):1752-1758.
PMID: 27543206
Although data are available on the change of expression/activity of drug-metabolizing enzymes in liver cirrhosis patients, corresponding data on transporter protein expression are not available. Therefore, using quantitative targeted proteomics,...
9.
Chapron B, Risler L, Phillips B, Collins C, Thummel K, Shen D
J Pharm Pharm Sci
. 2015 Apr;
18(1):101-11.
PMID: 25877445
Purpose: Telaprevir inhibits CYP3A resulting in drug-drug interactions (DDI) of unprecedented magnitude. We investigated the mechanisms by which telaprevir inhibits the oxidation of midazolam and tacrolimus in human liver microsomes...
10.